Biggest News Aggregation in the World
📰 Sysmex Group News

Sysmex Group News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Sysmex Group. Real-time updates on events, politics, business and more.

Sysmex : OncoGuide™ NCC Oncopanel System Receives Insurance Coverage as a Companion Diagnostic for Futibatinib, a Treatment for Advanced Biliary Tract Cancer -Today at 02:04 am

Aug. 30, 2023 Sysmex Corporation announces that the OncoGuide™ NCC Oncopanel System is now covered by health insurance in Japan as a companion diagnostic for...
National Cancer Center Sysmex Group Cancer Statistics National Registry Cancer Information Service National Cancer Incidence Data Sysmex Corporation

Research and Markets: Global Coagulation Analyzer Market Report 2022: Featuring Abbott, Thermo Fisher, Bio Group Medical System, Horiba, Siemens Healthineers & More

The "Coagulation Analyzer Market Analysis by Product, by Test by Technology, and by Region Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. The coagulation analyzer
United States South Africa South Korea Bpc Biosed Srl Asia Pacific Laura Wood

The Ajinomoto Foundation, Sysmex, and NEC initiate a cross-industry co-creation project to improve maternal and child health and nutrition in the Republic of Ghana

Contributing to Universal "Nutrition" Health CoverageTOKYO, May 27, 2022 - (JCN Newswire) - The Ajinomoto Foundation, Sysmex Corporation, and NEC Corporation are set to commence initiatives for a co-creation
Republic Of Ghana Office Of Health Initiative Af Nutrition Health Coverage Plan Sysmex Corporation Africa Health

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Hemostasis/Coagulation Analyzer Market by Product (Clinical Laboratory, consumables, reagents, PoCT, Manual, Automated), Test (PT,Fibrinogen,APTT, ACT, D Dimer), Technology, End User -Forecast to 2025 – KSU

“Coagulation analyzers market to register a CAGR of 5.7% from 2020 to 2025” The global coagulation analyzers market is projected to reach USD 5.0 bill
User In Mecklenburg Vorpommern United States Bpc Biosed Srl Asia Pacific Favorable Research Scenario

Sysmex and ThinkCyte Agree on Joint Development and Capital Alliance

Sysmex and ThinkCyte Agree on Joint Development and Capital Alliance - Commencing development of novel AI-based cell analyzers and testing techniques - News provided by Share this article Share this article TOKYO, May 12, 2021 /PRNewswire/ -- Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) and ThinkCyte, Inc. (HQ: Bunkyo-ku, Tokyo, Japan; CEO: Waichiro Katsuda) announced today the signing of joint development and investment agreements during May 2021 for the commercializ...
Bunkyo Ku Chuo Ku Waichiro Katsuda Hisashi Ietsugu Prnewswire Sysmex Corporation Thinkcyte Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science